Predictive performance of MRI and CT radiomics in predicting the response to induction chemotherapy in nasopharyngeal carcinoma: a network meta-analysis
Prädiktive Leistung von MRT- und CT-Radiomik zur Vorhersage des Ansprechens auf Induktionschemotherapie beim Nasopharynxkarzinom: eine Netzwerk-Metaanalyse
Frontiers in Oncology · 13.11.2025 · 15
DOI: 10.3389/fonc.2025.1590420 ↗Auf einen Blick
Zehn Studien mit 1.550 Personen zeigen eine gute Gesamtleistung radiomischer Modelle zur Vorhersage des Ansprechens auf Induktionschemotherapie beim Nasopharynxkarzinom. Die MRT-basierten Modelle schnitten besonders gut ab.
Fragestellung
Wie genau sagen verschiedene Radiomik-Modelle mit CT oder MRT das Ansprechen des Nasopharynxkarzinoms auf Induktionschemotherapie voraus?
Methode
Systematische Suche in PubMed, Embase, Web of Science und Cochrane Library; Netzwerk-Metaanalyse von CT- und MRT-Radiomics-Studien; Bewertung mit PROBAST, RQS und IBSI.
Ergebnisse
10 geeignete Studien mit 1.550 Personen. Gepoolte Sensitivität 0,86 (95 %-KI 0,78–0,91), Spezifität 0,69 (95 %-KI 0,62–0,75), AUC 0,83 (95 %-KI 0,70–0,91).
Einschränkungen
PROBAST: 7 Studien mit Bias-Risiko.
Schlussfolgerung der Autor:innen
Die Autor:innen schließen, dass Radiomik ein brauchbares exploratives Werkzeug zur Vorhersage der IC-Wirksamkeit beim NPC ist. MRT-basierte nichtlineare Modelle und klinisch-radiomische Fusionsmodelle erscheinen besonders vielversprechend.
Kernaussagen
- Gepoolte Sensitivität: 0,86; Spezifität: 0,69
- AUC der SROC: 0,83
- MRT-Modelle zeigten die beste Leistung
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Oncology, online erschienen am 13.11.2025. Verfasst von Yongjie Jian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Affiliated Hospital of Sichuan Nursing Vocational College, The Third People's Hospital of Sichuan Province, Chengdu, Sichuan…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objectives
To evaluate the accuracy of different radiomics methods in predicting the response of nasopharyngeal carcinoma (NPC) to induction chemotherapy (IC).
Methods
A systematic search was conducted in PubMed, Embase, Web of Science, and Cochrane Library. Radiomics studies utilizing CT and MRI were included in this network meta-analysis. The quality of the studies was appraised via the PROBAST, RQS, and IBSI guidelines. The sensitivity, specificity, and accuracy of different radiomics models were analyzed.
Results
Ten eligible studies involving 1550 subjects were included. The pooled sensitivity and specificity of the radiomics models were 0.86 (95% CI: 0.78-0.91) and 0.69 (95% CI: 0.62-0.75), respectively. The AUC based on the SROC curve was 0.83 (95% CI: 0.70-0.91). The predictive performance of each model was rated using SUCRA values. The MRI-based support vector machine radiomics model had the highest specificity, and accuracy, at 80.7% and 73.2%, respectively. The MRI-based SVM radiomics combined with clinical features model had the highest sensitivity (82.0%). Among the CT methods, the deep learning (DL)-based convolutional neural network model had the highest sensitivity, and accuracy, at 51.0% and 44.9%, respectively. The PROBAST showed that 7 studies were at risk for bias.
Conclusion
This study synthesized existing evidence to confirm that radiomics serves as a viable exploratory tool for predicting IC efficacy in NPC. MRI-based nonlinear models and clinical-radiomics fusion models exhibit considerable promise, whereas clinical translation necessitates three critical steps: (1) standardized protocols following IBSI/METRICS/RQS guidelines; (2) prospective multicenter validation; and (3) investigating tumor microenvironment mechanisms. These measures will facilitate the transition of radiomics from technical exploration to clinical utility. Systematic Review Registration https://www.crd.york.ac.uk/prospero/ , identifier CRD42024509331.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Affiliated Hospital of Sichuan Nursing Vocational College, The Third People's Hospital of Sichuan Province, Chengdu, Sichuan, China.
- Jinzhou Medical University Postgraduate Training Base (Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College), Hangzhou, Zhejiang, China.
- Center for Rehabilitation Medicine, Department of Radiology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
- Department of General Surgery, Shehong People's Hospital, Suining, Sichuan, China.
- Department of Medical Technology, Sichuan Nursing Vocational College, Chengdu, Sichuan, China.
- Department of Oncology, Affiliated Hospital of Sichuan Nursing Vocational College, The Third People's Hospital of Sichuan Province, Chengdu, Sichuan, China.
Zitieren
APA
Jian, Y., Peng, J., Yang, G., He, X., Wang, J., Yin, J., Shi, H., Tao, D., Lan, Q., Yang, Z., & Shu, Z. (2025). Predictive performance of MRI and CT radiomics in predicting the response to induction chemotherapy in nasopharyngeal carcinoma: a network meta-analysis. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1590420
Vancouver
Jian Y, Peng J, Yang G, He X, Wang J, Yin J, et al. Predictive performance of MRI and CT radiomics in predicting the response to induction chemotherapy in nasopharyngeal carcinoma: a network meta-analysis. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1590420
BibTeX
@article{Jian2025,
author = {Jian, Yongjie and Peng, Jiaxuan and Yang, Gan and He, Xiaojuan and Wang, Jing and Yin, Jun and Shi, Hui and Tao, Di and Lan, Qiyu and Yang, Zuogang and Shu, Zhenyu},
title = {Predictive performance of MRI and CT radiomics in predicting the response to induction chemotherapy in nasopharyngeal carcinoma: a network meta-analysis},
journal = {Frontiers in Oncology},
year = {2025},
volume = {15},
doi = {10.3389/fonc.2025.1590420}
}
EUVIMED